Your browser doesn't support javascript.
loading
Diagnostic markers and potential therapeutic agents for Sjögren's syndrome screened through multiple machine learning and molecular docking.
Zhou, Liqing; Wang, Haojie; Zhang, He; Wang, Fei; Wang, Wenjing; Cao, Qiong; Wei, Zhihao; Zhou, Haitao; Xin, Shiyong; Zhang, Jianguo; Shi, Xiaofei.
Afiliação
  • Zhou L; Department of Rheumatology and Immunology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Wang H; Department of Central Laboratory, Zhengzhou University, Luoyang Central Hospital, Luoyang, China.
  • Zhang H; Department of Rheumatology and Immunology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Wang F; Department of Rheumatology and Immunology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Wang W; Department of Rheumatology and Immunology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Cao Q; Department of Pathology, The Third Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
  • Wei Z; Department of Pathology, Yiluo Hospital of Luoyang, The Teaching Hospital of Henan University of Science and Technology, Luoyang, China.
  • Zhou H; Department of Central Laboratory, Zhengzhou University, Luoyang Central Hospital, Luoyang, China.
  • Xin S; Department of Urology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Zhang J; Department of Urology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Shi X; Department of Rheumatology and Immunology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Clin Exp Immunol ; 212(3): 224-238, 2023 06 05.
Article em En | MEDLINE | ID: mdl-36988140

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article